Elisa Buzzatti | Medicine | Research Excellence Award

Dr. Elisa Buzzatti | Medicine | Research Excellence Award

University Tor Vergata | Italy

Elisa Buzzatti is a physician–scientist and hematologist with advanced training in medical biotechnology and translational medicine. She earned her medical degree and specialization in Hematology at the University of Rome “Tor Vergata” and is currently enrolled in a doctoral program in Medical Biotechnology and Translational Medicine. Her clinical and research experience spans stem cell transplantation, acute and chronic leukemias, myeloproliferative disorders, and phase II–III clinical trials. She has contributed to numerous high-impact, peer-reviewed international publications and multicenter studies. Her research focuses on leukemia biology, immunotherapy, infectious complications, and measurable residual disease, aiming to improve precision and outcomes in hematologic malignancies.

                    Citation Metrics (Scopus)

400

300

200

100

10

0

 

Citations
241
Documents
35
h-index
10

Citations

Documents

h-index

View Scopus Profile   View Google Scholar Profile

Featured Publications

Shiva Vaheb Hosseinabadi | Genetics and Bioinformatics | Young Scientist Award

Ms. Shiva Vaheb Hosseinabadi | Genetics and Bioinformatics | Young Scientist Award

Zist Fanavari Novin biotechnology Institute | Iran

Dr. Shiva Vaheb Hosseinabadi is a molecular and cellular biologist and researcher currently serving as a molecular-techniques instructor and research supervisor at Zist Fanavari Novin Biotechnology Institute (since 2024). She earned her M.Sc. in Cellular and Molecular Sciences from Razi University (2019) and a B.Sc. in Molecular and Cellular Biology-Genetics from Islamic Azad University of Falavarjan. Her research and technical expertise span gene expression analysis, neurogenetics, cancer genomics, mutation analysis, next-generation sequencing (NGS), and bioinformatics. She has contributed to over a dozen peer-reviewed research articles — including studies on microRNA regulation in Parkinson’s disease models, co-frameshift mutations in acute myeloid leukemia, neurotoxicity attenuation via miR-361-5p, and exploration of lncRNA–miRNA networks in various cancers — with total publications exceeding 15 and cumulative citations in the low hundreds [exact citation count varies by database]. Dr. Hosseinabadi is proficient in molecular lab techniques (PCR/qPCR, cell culture, NGS), data analysis (R, Python, SPSS), and bioinformatics workflows. Her dual role as scientist and educator allows her to translate cutting-edge genetic research into practical training and application, contributing to advances in personalized medicine, neurogenetics, cancer biomarker discovery, and genomic diagnostics. Her ongoing work, including a 2025 book on cancer diagnostics and drug-resistance, underscores her commitment to bridging research and clinical translation.

Profile: Google Scholar

Featured Publications

Hosseinabadi, S. V., Tahamtan, H., Esfahani, M. M., Ghaedi-Heidari, R., Hashemi, M. S., Peymani, M., Sisakhtnezhad, S., Fahimi, H., & Ghaedi, K. (2025). Upregulation of miR-361-5p attenuates MPP+-induced neurotoxicity in dopaminergic SH-SY5Y cells as a Parkinson’s disease model. Journal of Biological Chemistry.

Roshani, H. R., Nasiri, A., Sattari, A., Rasaei, S., Karimian, P., Jannesari, F., … Hosseinabadi, S. V., & Azadeh, M. (2025). Uncovering an ADH1C–lncRNA regulatory axis linking alcohol metabolism to diagnostic potential in colorectal, breast, and gastric cancers.

Ghasroldasht, M. M., Hosseinabadi, S. V., Ebrahimi Askari, R., & Lotfalipour, R. (2025). Novel co-frameshift mutations in N- and C-terminal regions of CEBPA in acute myeloid leukemia: A case report. Cancer Genetics.

Esfahani, M. M., Mostashfi, M., Hosseinabadi, S. V., Hashemi, M. S., Peymani, M., & Nasr-Esfahani, M. H., et al. (2024). Unveiling the regulatory role of miR-101-3p on ZNF746 in a Parkinson’s disease cell model: Implications for therapeutic targeting. Neuroscience Research.